Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSysgroup Regulatory News (SYS)

Share Price Information for Sysgroup (SYS)

Share Price is delayed by 15 minutes
Get Live Data
18.00    0.00 (0.00%)
Bid:
17.00
Ask:
19.00
Spread: 2.00 (11.765%)
Market Cap: £15.07m
SYS Live PriceLast checked at - London Stock Exchange

Intraday Sysgroup Share Chart

Holding(s) in Company

10 Aug 2010 11:06

RNS Number : 8303Q
System C Healthcare plc
10 August 2010
 



 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii

System C Healthcare PLC

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to the notification obligation: iii

BlackRock UK Smaller Companies Fund

4. Full name of shareholder(s)  (if different from 3.):iv

5. Date of the transaction and date on which the threshold is crossed or reached: v

5th August 2010

6. Date on which issuer notified:

9th August 2010

7. Threshold(s) that is/are crossed or reached: vi, vii

Holding has gone below 5%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type of shares

if possible using the ISIN CODE

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

GB00B0940H91

6,964,039

6,964,039

5,700,383

5,700,383

N/A

4.91%

N/A

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date xiii

Exercise/ Conversion Period xiv

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financial instrument

Exercise price

Expiration date xvii

Exercise/ Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

5,700,383

4.91%

 

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi

 

 

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will cease to hold:

12. Date on which proxy holder will cease to hold voting rights:

13. Additional information:

BlackRock Threshold Reporting Team

14. Contact name:

Stuart Watchorn

15. Contact telephone number:

020 7743 5741; stuart.watchorn@blackrock.com

 

Note: Annex should only be submitted to the FSA not the issuer

Annex: Notification of major interests in share

A: Identity of the persons or legal entity subject to the notification obligation

Full name

(including legal form of legal entities)

 

BlackRock UK Smaller Companies Fund

 

Contact address

(registered office for legal entities)

 

 

33 King William Street, London, EC4R 9AS

Phone number & email

 

020 7743 5741; stuart.watchorn@blackrock.com

Other useful information

(at least legal representative for legal persons)

 

Stuart Watchorn

B: Identity of the notifier, if applicable

Full name

 

BlackRock, Inc

Contact address

 

 

33 King William Street, London, EC4R 9AS

Phone number & email

 

020 7743 5741; stuart.watchorn@blackrock.com

Other useful information

(e.g. functional relationship with the person or legal entity subject to the notification obligation)

Stuart Watchorn

C: Additional information

For notes on how to complete form TR-1 please see the FSA website.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLPMMMTMBMBBIM
Date   Source Headline
19th Jun 20261:51 pmRNSHolding(s) in Company
19th May 20267:00 amRNSChange of Registered Office
13th Apr 20267:00 amRNSYear End Trading Update
13th Mar 202610:11 amRNSTransfer of Shares to AI Board Adviser and TVR
13th Mar 202610:11 amRNSTransfer of Shares to AI Board Adviser and TVR
9th Feb 202610:15 amRNS-RIT Infrastructure Refresh Contract Win
3rd Feb 20264:13 pmRNSDirector/PDMR Dealing
29th Jan 20262:11 pmRNS-RContract win with the Scouts Association
22nd Jan 20269:34 amRNSHolding(s) in Company
22nd Dec 20252:08 pmRNSAcquisition of Saxis Group Limited
22nd Dec 20252:08 pmRNSAcquisition of Saxis Group Limited
9th Dec 202512:06 pmRNS-RAppointment of AI Adviser
3rd Dec 20257:00 amRNSHalf Year Results to 30 September 2025
25th Nov 20257:00 amRNSNotice of Results
16th Sep 20253:38 pmRNSResult of AGM
12th Sep 202510:51 amRNSDirector Dealing
8th Sep 202512:17 pmRNSExercise of Options and Total Voting Rights
3rd Sep 20257:00 amRNSGrant of Options and PDMR Dealings
8th Aug 20257:00 amRNSNotice of AGM and Publication of Accounts
29th Jul 202510:17 amRNSDirector/PDMR Dealing
24th Jul 20257:00 amRNSFinal Results for the year ended 31 March 2025
14th Jul 20257:00 amRNSNotice of Results
29th Apr 20257:00 amRNSYear End Trading Update
20th Mar 202511:34 amRNS-RSysGroup Joins Rubrik's Advanced Partner Program
29th Jan 20259:17 amRNSHolding(s) in Company
28th Jan 20257:00 amRNSDirector/PDMR Dealing
22nd Jan 20257:00 amRNSHolding(s) in Company
19th Dec 202412:45 pmRNSExercise of Options and Total Voting Rights
4th Dec 20244:00 pmRNSPresentation via Investor Meet Company
3rd Dec 20241:00 pmRNSDirector/PDMR Dealing
3rd Dec 20247:00 amRNSHalf Year Results to 30 September 2024
19th Nov 20247:00 amRNSAcquisition & Notice of Results
20th Sep 202411:00 amRNSResult of AGM
12th Sep 20247:00 amRNSAIM Rule 17 and Schedule 2(g) Disclosure
3rd Sep 20247:00 amRNSGrant of Options and Director/PDMR Dealings
21st Aug 20244:50 pmRNSGrant of Options and Director/PDMR Dealings
15th Aug 20247:00 amRNSNotice of AGM and Publication of Annual Report
31st Jul 20247:00 amRNSFinal Results for the year ended 31 March 2024
24th Jul 20247:00 amRNSNotice of Results
28th Jun 202410:10 amRNSHolding(s) in Company
28th Jun 20247:00 amRNSHolding(s) in Company
24th Jun 20244:12 pmRNSResult of General Meeting and Total Voting Rights
14th Jun 20247:00 amRNSResult of Retail Offer
7th Jun 20248:00 amRNSLaunch of Retail Offer
7th Jun 20247:00 amRNSResult of Oversubscribed Placing and Subscription
6th Jun 20245:11 pmRNSProposed Fundraising
3rd Jun 20247:00 amRNSBoard Changes
29th May 20247:00 amRNSStrategic Partnership
30th Apr 20247:00 amRNSTrading Update
29th Feb 20248:49 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.